Innovative Trials

Clinical Trials Issues Related to COVID-19
Topics Included: Access to Clinical Trials, Ensuring Quality, Innovative Trials, Regulatory Submissions + Approvals
SHARE TO:
Overview
The COVID-19 pandemic caused unprecedented disruptions to nearly every aspect of clinical research.
To help, CTTI led several efforts -- including conducting surveys, holding webinars, and developing resources -- with the goal of helping the clinical trials ecosystem adapt and move forward during the pandemic, including:
- Two playbooks of best practices: "Best Practices for Conducting Trials During the COVID-19 Pandemic" and "Best Practices for Designing High-Quality, Diverse COVID-19 Trials".
- Recordings of six CTTI COVID-19 webinars are available:
- Identifying Best Practices for Conducting Clinical Trials with FDA's COVID-19 Guidance
- Designing High-Quality, Streamlined COVID-19 Trials
- Solutions for Switching to Remote and Virtual Visits
- Engaging Racial and Ethnic Minority Patient Populations during the Pandemic
- Using Master Protocol Studies for Effective COVID-19 Treatments
- The State of U.S. COVID-19 Treatment Clinical Trials
- A daily searchable spreadsheet of the COVID-19-related studies posted on ClinicalTrials.gov is also available.
